In Davenport, Iowa, long winters and limited specialist access can make weight management harder than it should be. Rybelsus® is the FDA-approved Oral tablet Semaglutide product manufactured by Novo Nordisk since 2019. Weight Method offers a separate option: licensed Iowa providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for Davenport starts at $199/month — medication, provider evaluation, ongoing care, and shipping included.
FDA-approved Rybelsus prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Davenport is already seeing results
Rybelsus in Davenport, IA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Rybelsus to patients in Davenport from $199/month with virtual consultations and direct-to-door shipping.
Rybelsus® by Novo Nordisk is the FDA-approved Oral tablet Semaglutide product, taken Once daily and approved in 2019 for Type 2 diabetes. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Davenport residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Urban residents in Davenport are often surrounded by healthcare options yet still struggle to access GLP-1 treatment. Primary care physicians may not specialize in GLP-1 prescribing, and specialist clinics charge $500+ per visit. Weight Method's all-inclusive compounded Semaglutide program — consultation, medication, and ongoing support at $199/month — is built for the urban patient who values quality and efficiency. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Iowa and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.